About us
Research Library
Company Pages
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Nexstim
Redx Pharma
Scancell
Contact us
More Company News
Scancell
Phase 2 SCIB1 trial expanded
15 Jun 2022
Read More
Scancell
First patient dosed in Modi-1 Phase 1
13 Jun 2022
Read More
Scancell
Modi-1 Phase 1/2 trial open for recruitment
11 Apr 2022
Read More
Scancell
Update on COVIDITY trial
29 Mar 2022
Read More
Scancell
Scancell progresses its new anti-glycan mAb
17 Mar 2022
Read More
Scancell
Update on COVIDITY Phase I trial
31 Jan 2022
Read More
Scancell
Interim results to 31 October 2021
26 Jan 2022
Read More
Scancell
First patient dosed in SCIB1 Phase II trial
19 Nov 2021
Read More
Scancell
Results for the year ended 30 April 2021
29 Oct 2021
Read More
Scancell
First subject dosed in South Africa Phase I COVIDITY trial
05 Oct 2021
Read More
1
2
3
4
…
7
Return to Scancell
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).
About us
Research Library
Company Pages
▼
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Nexstim
Redx Pharma
Scancell
Contact us